Growth of primary tumors receiving in situ Flt3L and TLR3/CD40 agonists was not altered by irradiating distant tumors (Fig. 2f), emphasizing the requirement for targeting the same tumor to achieve maximal tumor control by ISIM. This evidence concerns the gene CD40 and neoplasm.